Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H26FN3O2 |
Molecular Weight | 419.4912 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C2/CCCN([C@@H](C)C3=CC=C(F)C=C3)C2=O)=CC=C1N4C=NC(C)=C4
InChI
InChIKey=PUOAETJYKQITMO-LANLRWRYSA-N
InChI=1S/C25H26FN3O2/c1-17-15-28(16-27-17)23-11-6-19(14-24(23)31-3)13-21-5-4-12-29(25(21)30)18(2)20-7-9-22(26)10-8-20/h6-11,13-16,18H,4-5,12H2,1-3H3/b21-13+/t18-/m0/s1
Molecular Formula | C25H26FN3O2 |
Molecular Weight | 419.4912 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.eisai.com/news/news200616.htmlCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24085193
Sources: http://www.eisai.com/news/news200616.html
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24085193
E-2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease. E-2012, a new chemical entity discovered by Eisai, has shown some potential in non-clinical studies to reduce the production of beta-amyloid Abeta 40/42 by modulating the function of gamma-secretase without interfering with the Notch-processing.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094135 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22650177 |
81.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26689589
Beagle dogs were given a single oral dose of 20 and80 mg/kg E-2012 with a dosing interval of at least 1 week
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24085193
E-2012 was shown to have concentration-dependent inhibitory effects on cholesterol biosynthesis in primary culture of rat hepatocytes and HepG2 cells with IC50 values of 11.0, and 15.1 nmol/l, respectively. Cholesterol synthesis in the rat lens was also reduced by E-2012 at 100 nmol/l and higher.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:42:51 GMT 2023
by
admin
on
Sat Dec 16 10:42:51 GMT 2023
|
Record UNII |
3LSD4Y5F0F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
870843-42-8
Created by
admin on Sat Dec 16 10:42:52 GMT 2023 , Edited by admin on Sat Dec 16 10:42:52 GMT 2023
|
PRIMARY | |||
|
DB05171
Created by
admin on Sat Dec 16 10:42:52 GMT 2023 , Edited by admin on Sat Dec 16 10:42:52 GMT 2023
|
PRIMARY | |||
|
11560787
Created by
admin on Sat Dec 16 10:42:52 GMT 2023 , Edited by admin on Sat Dec 16 10:42:52 GMT 2023
|
PRIMARY | |||
|
3LSD4Y5F0F
Created by
admin on Sat Dec 16 10:42:52 GMT 2023 , Edited by admin on Sat Dec 16 10:42:52 GMT 2023
|
PRIMARY | |||
|
DTXSID30468614
Created by
admin on Sat Dec 16 10:42:52 GMT 2023 , Edited by admin on Sat Dec 16 10:42:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |